OpportunityTitle: Planning Grants for Translating CKD Research into Improved Clinical Outcomes (R34)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages NIH Clinical Trial Planning Grant (R34) applications from institutions/organizations to assess the feasibility of testing the effectiveness of interventions for the prevention, treatment and management of chronic kidney disease that have a high likelihood of being widely adopted and sustained in a wide range of health care settings and in individuals and communities at highest risk. The approaches to be tested must be based on widely accepted interventions previously demonstrated to be efficacious in clinical trials. The proposed research must target the prevention or control of chronic kidney disease and/or its complications.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;